Home LiteratureArticle Details
PMID: 7624329 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.

Wolkowicz R, Peled A, Elkind NB, Rotter V

Abstract

DNA-binding activity of the wild-type p53 is central to its function in vivo. However, recombinant or in vitro translated wild-type p53 proteins, unless modified, are poor DNA binders. The fact that the in vitro produced protein gains DNA-binding activity upon modification at the C terminus raises the possibility that similar mechanisms may exist in the cell. Data presented here show that a C-terminal alternatively spliced wild-type p53 (ASp53) mRNA expressed by bacteria or transcribed in vitro codes for a p53 protein that efficiently binds DNA. Our results support the conclusion that the augmented DNA binding activity of an ASp53 protein is probably due to attenuation of the negative effect residing at the C terminus of the wild-type p53 protein encoded by the regularly spliced mRNA (RSp53) rather than acquisition of additional functionality by the alternatively spliced C' terminus. In addition, we found that ASp53 forms a complex with the non-DNA-binding RSp53, which in turn blocks the DNA-binding activity of ASp53. Interaction between these two wild-type p53 proteins may underline a mechanism that controls the activity of the wild-type p53 protein in the cell.

MeSH Terms
Alternative Splicing Amino Acid Sequence Animals Base Sequence Binding, Competitive DNA/metabolism Mice Molecular Sequence Data Protein Binding Protein Biosynthesis RNA, Messenger/metabolism Recombinant Proteins/metabolism Sequence Deletion Structure-Activity Relationship Tumor Suppressor Protein p53/genetics,metabolism
Chemicals
RNA, Messenger Recombinant Proteins Tumor Suppressor Protein p53 DNA
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wolkowicz R
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Peled A
Elkind N B
Rotter V
References (30)
30 references, click to expand
  1. Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells.
    EMBO J. 1994 Oct 17;13(20):4823-30 PMID: 7957051
  2. How loops, beta sheets, and alpha helices help us to understand p53.
    Cell. 1994 Aug 26;78(4):543-6 PMID: 8069906
  3. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.
    Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1958-62 PMID: 1705714
  4. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  5. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Nucleic Acids Res. 1991 Oct 11;19(19):5191-8 PMID: 1923804
  6. Alternatively spliced p53 RNA in transformed and normal cells of different tissue types.
    Nucleic Acids Res. 1992 Apr 25;20(8):1979-81 PMID: 1579500
  7. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Mol Cell Biol. 1992 Jun;12(6):2866-71 PMID: 1588974
  8. Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.
    Nucleic Acids Res. 1992 Jul 11;20(13):3435-41 PMID: 1630914
  9. Regulation of the specific DNA binding function of p53.
    Cell. 1992 Nov 27;71(5):875-86 PMID: 1423635
  10. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
    EMBO J. 1993 Mar;12(3):1029-37 PMID: 8458321
  11. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  12. Activation of the cryptic DNA binding function of mutant forms of p53.
    Nucleic Acids Res. 1993 Jul 11;21(14):3167-74 PMID: 8341590
  13. p53: at the crossroads of molecular carcinogenesis and risk assessment.
    Science. 1993 Dec 24;262(5142):1980-1 PMID: 8266092
  14. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Genes Dev. 1993 Dec;7(12B):2556-64 PMID: 8276238
  15. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  16. Monoclonal antibodies specific for simian virus 40 tumor antigens.
    J Virol. 1981 Sep;39(3):861-9 PMID: 6169844
  17. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.
    Mol Cell Biol. 1985 Jan;5(1):127-32 PMID: 2580227
  18. Monoclonal antibody analysis of p53 expression in normal and transformed cells.
    J Virol. 1986 Aug;59(2):444-52 PMID: 2426467
  19. Immunologically distinct p53 molecules generated by alternative splicing.
    Mol Cell Biol. 1986 Sep;6(9):3232-9 PMID: 3023970
  20. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
    EMBO J. 1990 May;9(5):1595-602 PMID: 1691710
  21. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  22. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Science. 1990 Aug 31;249(4972):1049-51 PMID: 2144364
  23. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
    Mol Cell Biol. 1991 Jan;11(1):12-9 PMID: 1986215
  24. A potential transcriptional activation element in the p53 protein.
    Oncogene. 1990 Dec;5(12):1829-32 PMID: 2284102
  25. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  26. Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.
    Mol Cell Biol. 1994 Mar;14(3):1698-708 PMID: 8114705
  27. p53: a glimpse at the puppet behind the shadow play.
    Science. 1994 Jul 15;265(5170):334-5 PMID: 8023155
  28. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  29. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Science. 1994 Jul 15;265(5170):386-91 PMID: 8023159
  30. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
    Oncogene. 1995 Mar 16;10(6):1167-74 PMID: 7535417
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1995-07-18
Pages
6842-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC41425
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]